Epstein AB - Search Results

1

Efficacy and response with olopatadine versus epinastine in ocular allergic symptoms: a post hoc analysis of data from a conjunctival allergen challenge study.

Finegold I, Granet DB, D'Arienzo PA, Epstein AB. Finegold I, et al. Among authors: epstein ab. Clin Ther. 2006 Oct;28(10):1630-8. doi: 10.1016/j.clinthera.2006.10.003. Clin Ther. 2006. PMID: 17157118 Clinical Trial.

2

Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the conjunctival allergen challenge model.

Lanier BQ, Finegold I, D'Arienzo P, Granet D, Epstein AB, Ledgerwood GL. Lanier BQ, et al. Among authors: epstein ab. Curr Med Res Opin. 2004 Aug;20(8):1227-33. doi: 10.1185/030079904125004330. Curr Med Res Opin. 2004. PMID: 15324525 Clinical Trial.

3

Comparison of the clinical efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and loteprednol etabonate 0.2% ophthalmic suspension in the conjunctival allergen challenge model.

Berdy GJ, Stoppel JO, Epstein AB. Berdy GJ, et al. Among authors: epstein ab. Clin Ther. 2002 Jun;24(6):918-29. doi: 10.1016/s0149-2918(02)80007-8. Clin Ther. 2002. PMID: 12117082 Clinical Trial.

4

Efficacy of once-daily olopatadine 0.2% ophthalmic solution compared to twice-daily olopatadine 0.1% ophthalmic solution for the treatment of ocular itching induced by conjunctival allergen challenge.

Abelson MB, Spangler DL, Epstein AB, Mah FS, Crampton HJ. Abelson MB, et al. Among authors: epstein ab. Curr Eye Res. 2007 Dec;32(12):1017-22. doi: 10.1080/02713680701736558. Curr Eye Res. 2007. PMID: 18085465 Clinical Trial.

5

Evaluation of comfort using olopatadine hydrochloride 0.1% ophthalmic solution in the treatment of allergic conjunctivitis in contact lens wearers compared to placebo using the conjunctival allergen-challenge model.

Brodsky M, Berger WE, Butrus S, Epstein AB, Irkec M. Brodsky M, et al. Among authors: epstein ab. Eye Contact Lens. 2003 Apr;29(2):113-6. doi: 10.1097/01.ICL.0000063576.32087.F7. Eye Contact Lens. 2003. PMID: 12695716 Clinical Trial.

6

Ocular allergy.

Epstein AB. Epstein AB. Optometry. 2003 Dec;74(12):795-7. Optometry. 2003. PMID: 14677732 Review. No abstract available.

7

Reduction in bacterial load using hypochlorous acid hygiene solution on ocular skin.

Stroman DW, Mintun K, Epstein AB, Brimer CM, Patel CR, Branch JD, Najafi-Tagol K. Stroman DW, et al. Among authors: epstein ab. Clin Ophthalmol. 2017 Apr 13;11:707-714. doi: 10.2147/OPTH.S132851. eCollection 2017. Clin Ophthalmol. 2017. PMID: 28458509 Free PMC article.

8

Management of allergic conjunctivitis: an evaluation of the perceived comfort and therapeutic efficacy of olopatadine 0.2% and azelastine 0.05% from two prospective studies.

Epstein AB, Van Hoven PT, Kaufman A, Carr WW. Epstein AB, et al. Clin Ophthalmol. 2009;3:329-36. doi: 10.2147/opth.s5223. Epub 2009 Jun 2. Clin Ophthalmol. 2009. PMID: 19668586 Free PMC article.

9

In the aftermath of the Fusarium keratitis outbreak: What have we learned?

Epstein AB. Epstein AB. Clin Ophthalmol. 2007 Dec;1(4):355-66. Clin Ophthalmol. 2007. PMID: 19668512 Free PMC article.

10

Contact lens care products effect on corneal sensitivity and patient comfort.

Epstein AB. Epstein AB. Eye Contact Lens. 2006 May;32(3):128-32. doi: 10.1097/01.icl.0000178850.55802.1c. Eye Contact Lens. 2006. PMID: 16702866 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters